Osiris Therapeutics, Inc. Net Profit Margin 2010-2018 | OSIR
Osiris Therapeutics, Inc. net profit margin from 2010 to 2018. Net profit margin can be defined as net Income as a portion of total sales revenue.
Net Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Net Income |
Net Margin |
2018-12-31 |
$0.14B |
$0.04B |
25.87% |
2018-09-30 |
$0.14B |
$0.01B |
4.44% |
2018-06-30 |
$0.13B |
$0.01B |
7.75% |
2018-03-31 |
$0.12B |
$0.01B |
7.26% |
2017-12-31 |
$0.12B |
$0.01B |
7.56% |
2017-09-30 |
$0.10B |
$-0.03B |
-32.29% |
2017-06-30 |
$0.09B |
$-0.04B |
-43.96% |
2017-03-31 |
$0.09B |
$-0.04B |
-46.51% |
2015-12-31 |
$0.08B |
$-0.04B |
-46.25% |
2015-09-30 |
$0.09B |
$0.00B |
2.25% |
2015-06-30 |
$0.08B |
$0.00B |
4.94% |
2015-03-31 |
$0.07B |
$0.00B |
1.43% |
2014-12-31 |
$0.06B |
$-0.00B |
-1.69% |
2014-09-30 |
$0.05B |
$0.05B |
100.00% |
2014-06-30 |
$0.04B |
$0.05B |
118.42% |
2014-03-31 |
$0.03B |
$0.04B |
143.33% |
2013-12-31 |
$0.02B |
$0.04B |
170.83% |
2013-09-30 |
$0.02B |
$-0.01B |
-63.16% |
2013-06-30 |
$0.01B |
$-0.01B |
-92.86% |
2013-03-31 |
$0.01B |
$-0.01B |
-118.18% |
2012-12-31 |
$0.01B |
$-0.01B |
-137.50% |
2012-09-30 |
$0.01B |
$-0.00B |
-50.00% |
2012-06-30 |
$0.00B |
$0.00B |
100.00% |
2012-03-31 |
$0.00B |
$0.01B |
500.00% |
2011-12-31 |
$0.00B |
$0.02B |
1500.00% |
2011-09-30 |
$0.00B |
$0.01B |
inf% |
2011-06-30 |
$0.00B |
$0.02B |
inf% |